Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug ...

In the second part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, discusses the common misconceptions supply chain leaders might have around the ...

The designation allows pharmacists to substitute it for Humira without prescriber approval (per state law), which expands ...

In the first part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, describes the disparity in organizations utilizing supply-chain specific ...

Just as importantly, Serialization 2.0 enables better decision-making across the enterprise by unlocking data trapped in ...

The rebrand creates a platform that is expected enhance the way life sciences companies bring their therapies to market.

As this medical approach continues to become more widely adopted, the industry must adapt to help provide precise, compliant, ...

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

In an interview with Applied Clinical Trials, Michel van Harten, MD, CEO of myTomorrows, explained how AI can help address clinical trial diversity and access challenges by reducing physician workload ...

Bruce Leuchter, CEO, Neurvati, discusses the indispensable role of patient advocates—particularly in rare and serious disease drug development—in shaping trial design, site selection, and regulatory ...

Addressing drug shortages requires the industry to embrace innovative advanced manufacturing processes underpinned by real-time data. The pharmaceutical industry faces an urgent challenge: frequent ...